# Myocardial Perfusion and Scarring in Congenital Heart Disease

> **NCT01639937** · — · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 18 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01639937
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10-24
- **Primary completion:** 2017-04-01
- **Final completion:** 2019-12-12
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** PI is leaving NHLBI, sample size is too small.
- **Last updated:** 2021-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639937, "Myocardial Perfusion and Scarring in Congenital Heart Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01639937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*